Surge Therapeutics
Biotechnology, 225 Franklin Street, Cambridge, , 2110, Massachusetts, United States, 1-10 Employees
Phone Number: +17*********
Who is SURGE THERAPEUTICS
SURGE seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer immunotherapy is deployed -- focusing 100% of the effective dose at the right place a...
Read More
-
Headquarters: 225 Franklin Street, Cambridge, Massachusetts, 2110, United States
-
Date Founded: 2001
-
Employees: 1-10
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 325414 |
Show More
Does something look wrong? Fix it. | View contact records from SURGE THERAPEUTICS
SURGE Therapeutics Org Chart and Mapping
Email
Phone
Similar Companies to SURGE Therapeutics
Ensoma
-
51-200
-
$ 10 Million to 25 Million
Phathom Pharmaceuticals
-
201-500
-
$ 10 Million to 25 Million
ReCode Therapeutics
-
11-50
-
$ 10 Million to 25 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding SURGE Therapeutics
Answer: SURGE Therapeutics's headquarters are located at 225 Franklin Street, Cambridge, , 2110, Massachusetts, United States
Answer: SURGE Therapeutics's phone number is +17*********
Answer: SURGE Therapeutics's official website is https://surgetx.com
Answer: SURGE Therapeutics's revenue is $10 Million to $25 Million
Answer: SURGE Therapeutics's SIC: 2836
Answer: SURGE Therapeutics's NAICS: 325414
Answer: SURGE Therapeutics has 1-10 employees
Answer: SURGE Therapeutics is in Biotechnology
Answer: SURGE Therapeutics top competitors include: Ensoma , Phathom Pharmaceuticals , ReCode Therapeutics
Answer: SURGE Therapeutics contact info: Phone number: +17********* Website: https://surgetx.com
Answer: SURGE seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer immunotherapy is deployed -- focusing 100% of the effective dose at the right place and at the right time. Surgery is the standard of care for most patients with solid tumors, and we are working tirelessly to ensure that nobody grieves the loss of a loved one to preventable post-surgical cancer recurrence.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month